Author/Creator: Jenner, Peter - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Jenner, Peter

1. 'Dopamine agonist Phobia' in Parkinson's disease: when does it matter? Implications for non-motor symptoms and personalized medicine. (1st September 2020)

Authors:: Rota, Silvia; Boura, Iro; Batzu, Lucia; Titova, Nataliya; Jenner, Peter; Falup-Pecurariu, Cristian; Chaudhuri, K Ray
Journal:: Expert review of neurotherapeutics
Issue:: Volume 20:Number 9(2020)
Page Start:: 953
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. A cup of coffee a day keeps dyskinesia away?. Issue 3 (27th February 2013)

Authors:: Jenner, Peter
Journal:: Movement disorders
Issue:: Volume 28:Issue 3(2013)
Page Start:: 265
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. A glimmer of light at the end of the tunnel?. Issue 10 (18th September 2017)

Authors:: Jenner, Peter
Journal:: Movement disorders
Issue:: Volume 32:Issue 10(2017)
Page Start:: 1343
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. A late appearance by the dopamine D‐3 receptor. Issue 9 (7th July 2014)

Authors:: Jenner, Peter
Journal:: Movement disorders
Issue:: Volume 29:Issue 9(2014)
Page Start:: 1094
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Apomorphine - pharmacological properties and clinical trials in Parkinson's disease. (December 2016)

Authors:: Jenner, Peter; Katzenschlager, Regina
Journal:: Parkinsonism & related disorders
Issue:: Volume 33(2016)Supplement 1
Page Start:: S13
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Apomorphine infusion in advanced Parkinson disease. Issue 12 (December 2018)

Authors:: Antonini, Angelo; Jenner, Peter
Journal:: Nature reviews
Issue:: Volume 14:Issue 12(2018)
Page Start:: 693
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Brain Cytochrome P450 in the Rat. (February 1996)

Authors:: Riedl, Andrew G.; Watts, Paul M.; Edwards, Robert J.; Boobis, Alan R.; Jenner, Peter
Journal:: Biochemical Society transactions
Issue:: Volume 24:Number 1(1996)
Page Start:: 52S
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Can adenosine A2A receptor antagonists be used to treat cognitive impairment, depression or excessive sleepiness in Parkinson's disease?. (November 2020)

Authors:: Jenner, Peter; Mori, Akihisa; Kanda, Tomoyuki
Journal:: Parkinsonism & related disorders
Issue:: Volume 80(2020) Supplement 1
Page Start:: S28
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Can adenosine A2A receptor antagonists modify motor behavior and dyskinesia in experimental models of Parkinson's disease?. (November 2020)

Authors:: Kanda, Tomoyuki; Jenner, Peter
Journal:: Parkinsonism & related disorders
Issue:: Volume 80(2020) Supplement 1
Page Start:: S21
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. Can therapeutic strategies prevent and manage dyskinesia in Parkinson's disease? An update. Issue 12 (2nd December 2019)

Authors:: Leta, Valentina; Jenner, Peter; Chaudhuri, K. Ray; Antonini, Angelo
Journal:: Expert opinion on drug safety
Issue:: Volume 18:Issue 12(2019)
Page Start:: 1203
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗